Stocksigma LogoStocksigma Logo

AstraZeneca Pharma India Q2 Results and Key Leadership Appointments

AstraZeneca Pharma India reported Q2'26 revenue from operations of Rs 7,291.0 mn, up 30.4% YoY from Rs 5,590.9 mn, with profit after tax rising 15.0% YoY

AstraZeneca Pharma India Q2 Results and Key Leadership Appointments

AstraZeneca Pharma India Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 11:26 pm

AstraZeneca Pharma India Q2 Results and Key Leadership Appointments AstraZeneca Pharma India reported Q2'26 revenue from operations of Rs 7,291.0 mn, up 30.4% YoY from Rs 5,590.9 mn, with profit after tax rising 15.0% YoY to Rs 623.3 mn. Profit before tax stood at Rs 884.9 mn after Rs 149.6 mn in exceptional items. For H1'26, revenue reached Rs 14,118.9 mn while PAT stood at Rs 1,002.6 mn. The board appointed Atul Tandon as CFO effective 9th Nov'26 and Krishnamurthy Narayanan Iyer as Independent Director for five years from 5th Nov'26.

Original exchange filing (PDF)

More announcements from AstraZeneca Pharma India Ltd

All AstraZeneca Pharma India Ltd announcements